| Title | Date | PubMed ID |
|---|
| Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease. | 2014 Sep 23 | 25196915 |
| Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. | 2013 Nov 15 | 24080461 |
| Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. | 2013 Oct | 23994330 |
| Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. | 2013 Jul | 23747811 |
| Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins. | 2013 May | 23452147 |
| Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease. | 2013 May | 23633583 |
| Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors. | 2011 Dec 8 | 22014094 |
| Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. | 2011 Nov | 21854807 |
| Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. | 2011 May 15 | 21470860 |
| Increase of SARS-CoV 3CL peptidase activity due to macromolecular crowding effects in the milieu composition. | 2010 Dec | 21087086 |